“Risk of Arterial and Venous Thromboembolic Events With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor A (VEGF-A): A Systematic Review and Meta-Analysis”. 2020. Global Journal of Medical Research 20 (B1): 71-85. https://medicalresearchjournal.org/index.php/GJMR/article/view/1952.